Shopping Cart
Remove All
Your shopping cart is currently empty
Ethamsylate (Dicynene) usually is used as a hemostatic drug, which increases capillary endothelial resistance and platelet adhesion, and inhibits biosynthesis and action of prostaglandins.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 mg | $29 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $29 | In Stock | In Stock |
| Description | Ethamsylate (Dicynene) usually is used as a hemostatic drug, which increases capillary endothelial resistance and platelet adhesion, and inhibits biosynthesis and action of prostaglandins. |
| In vitro | High concentrations of Ethamsylate were able to remove superoxide radicals. In the presence of Ethamsylate, arachidonic acid, thromboxane A2, collagen, and the calcium carrier A23187 promoted the induction of human platelet aggregation and the release of ATP.Ethamsylate inhibited the production of prostaglandins in the microsomes of pregnant women's uterine myometrium at an IC50 of 0.5 mM. Ethamsylate was highly effective in inhibiting hydroxyl radicals (OH.) at concentrations of 0.1-10 μM. |
| In vivo | High concentrations of Ethamsylate were able to remove superoxide radicals. In the presence of Ethamsylate, arachidonic acid, thromboxane A2, collagen, and the calcium carrier A23187 promoted the induction of human platelet aggregation and the release of ATP.Ethamsylate inhibited the production of prostaglandins in the microsomes of pregnant women's uterine myometrium at an IC50 of 0.5 mM. Ethamsylate was highly effective in inhibiting hydroxyl radicals (OH.) at concentrations of 0.1-10 μM. |
| Synonyms | Etamsylate, Dicynene, Cyclonamine, Aglumin |
| Molecular Weight | 263.31 |
| Formula | C10H17NO5S |
| Cas No. | 2624-44-4 |
| Smiles | Oc1cc(c(O)cc1)S(=O)(=O)O.C(NCC)C |
| Relative Density. | 1.3441 g/cm3 (Estimated) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (189.89 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2.5 mg/mL (9.49 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.